INSIDE PHARMA

INSIDE PHARMA

Share this post

INSIDE PHARMA
INSIDE PHARMA
THE YAWNING GAP BETWEEN PHARMA COMPANIES AND ITS CUSTOMERS

THE YAWNING GAP BETWEEN PHARMA COMPANIES AND ITS CUSTOMERS

You probably didn't think about this...

Hedley Rees's avatar
Hedley Rees
Feb 28, 2022
∙ Paid
4

Share this post

INSIDE PHARMA
INSIDE PHARMA
THE YAWNING GAP BETWEEN PHARMA COMPANIES AND ITS CUSTOMERS
Share

IT’S A ONE-WAY SYSTEM

This diagram below represents how pharma customers (aka patients) are left by pharma companies to fend for themselves.

On the left-hand side, we see what is now known as the ‘manufacturer’.

That in itself is a distortion of the truth never corrected by pharma companies. They must have been given a license to sell their products, and as such, they are much more than ‘the manufacturer’—they are totally responsible for everything that goes on in the supply chain to market; also, they are responsible for post-approval monitoring of safety and running what are known as Phase IV clinical studies.

In practice, once the pharma company sells its product to wholesalers, they wipe their hands of it and leave it to its own devices, circulating around the healthcare system.

It’s a one-way only system.

THAT’S NOT THE END OF HAND-WIPING

In nearly all case, the pharma company didn’t actually develop or manufacture the product itself. They left it to contract development and manufactu…

This post is for paid subscribers

Already a paid subscriber? Sign in
© 2025 Hedley Rees
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture

Share